BALLARD PARTNERS

Lobbying for GENETIX BIOTHERAPEUTICS INC. · Biotechnology company

Filing Registration

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · posted Dec 29, 2025

Lobbying activity 1

Health Issues

Expanded access for genetic treatments for Sickle Cell Disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem